Despite Growing Number Of Talcum Powder Lawsuit Filings, Financial Analysts Say J & J Investors Shouldn’t Worry
September 28, 2016 – – TheProductLawyers.com reports on a recent article done by gurufocus.com indicating that despite increased lawsuits against Johnson & Johnson, stocks in the company could still be profitable.
The article states that U.S. sales for Johnson & Johnson were up 7.4% with the overall growth rate coming at 3.9% year over year. The company also revised its expectation on sales for the year 2016 to about $72 billion from an earlier estimate of about $69 billion while EPS is now expected to come at about $6.63 to $6.73 compared to first-quarter guidance of $6.53 to $6.68, the article said. Though the company has been hit with many lawsuits concerning their products, the site states that the company still stands out as a good stock for investors.
The first talcum powder lawsuit was filed in 2009 by a woman from Sioux Falls, South Dakota. The plaintiff was diagnosed with ovarian cancer in 2006 when she was 49 years old, according to an article by Huffington Post. The plaintiff filed the complaint claiming Johnson & Johnson should be held accountable for gross negligence and fraud. Though a jury confirmed the association between cancer and talcum powder, the plaintiff was offered no compensatory damages.
Many women have claimed that the use of Johnson & Johnson’s powder for feminine hygiene purposes has been directly linked to their development of ovarian cancer. Thousands of plaintiffs have filed suits so far concerning the alleged effects of these powders. Many have already been awarded millions of dollars in compensation and lawsuit numbers are continuing to grow. Most of the filed cases are pending in a Missouri federal court, while others have been filed in New Jersey, where Johnson & Johnson is headquartered.
Banville Law has many years of experience fighting large pharmaceutical companies who have put dangerous drugs and devices onto the market, foregoing public safety for corporate greed.
The firm is looking to assist those who believe they have been directly affected by the use of Johnson’s talcum powder. Affected individuals may be entitled to financial compensation and legal action. Banville Law is currently offering free consultations to individuals who qualify.
For more information, to schedule a consultation or to ask questions contact Banville Law at (888) 976-6742.
165 West End Ave #1h,
New York, NY 10023